Princeton, New Jersey, November 27, 2002 — AOAC INTERNATIONAL, a professional scientific association dedicated to the validation of analytical methods and quality laboratory management, announced that it has awarded fellowship status to two Covance employees, Mr. Wayne Ellefson and Mr. Darryl Sullivan. It is a great honor for Covance to have received this recognition, particularly for two people in one year. Covance continues to enhance its presence in the marketplace as the premier laboratory for analytical testing services and the recent AOAC awards are a testimony to the confidence that the scientific and regulatory communities have placed in Covance.
Mr. Sullivan has been employed at Covance for 24 years and has been an active member of AOAC for 22 years. He has held many positions within the association, most recently being appointed Chair of the Official Methods Board. Also, Mr. Sullivan is the current Chair of the AOAC Task Force on Dietary Supplements. Mr. Ellefson has been employed at Covance for 31 years and has most recently supported AOAC as the Chair of the Annual Meeting Program Committee.
AOAC is a private, not-for-profit association dedicated to the development and validation of analytical methods, the improvement of quality assurance procedures in laboratories, and the professional development of scientists. The latest information about AOAC's methods validation programs, training courses, membership, publications, and proficiency testing program can be found at: http://www.aoac.org.
As a leader in food safety and nutritional testing, Covance's scientists help food manufacturers navigate the path from development to product release by providing accurate scientific data and dependable regulatory expertise. To maintain this leadership position, Covance continuously seeks ways to better service their clients. Examples of this dedication include the expansion of the Analytical Testing Services in Madison Wisconsin, and the development of a new method to detect the presence of acrylamide in food. The expanded laboratory facilities are nearing completion and are expected to enhance the ability to support both existing products and the stream of new products entering the conventional food and nutraceutical markets. The newly offered acrylamide testing was developed in response to a recent report by the Swedish National Food Administration, which sparked international concern over this potential cancer-causing agent in food. The testing method has proven effective for a variety of carbohydrate-rich foods and Covance is extending the method applicability through cross validation in different matrices. From nutritional analysis and labeling to stability testing and clinical studies of dietary supplements, Covance adapts to clients' needs to help reduce the time and cost of drug development.
Covance [NYSE: CVD], with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with 2001 pro forma revenues of $800 million, operations currently in 17 countries, and approximately 6,900 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through the website, http://www.covance.com in the About Covance area.